Impairment of bronchoprotection by nitric oxide in severe asthma

Lancet

Volumn 350, Issue 9087, 1997, Pages 1297-1298

  Ricciardolo, Fabio L M ^b   Di Maria, Giuseppe U ^a   Mistretta, Antonino ^b   Sapienza, Maria A ^b   Geppetti, Pierangelo ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; ATOPY; BRONCHODILATATION; BRONCHUS MUCOSA; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL;

EID: 0031560193     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62474-9     Document Type: Article

References (5)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-44.
2. Ricciardolo FLM, Geppetti P, Mistretta A, et al. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 1996; 348: 374-77.
3. Figini M, Ricciardolo FLM, Javdan P, et al. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea-pig trachea is nitric oxide. Am J Respir Crit Care Med 1996; 153: 918-23.
4. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA. Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-35.
5. Moncada S, Higgs A. The L-Arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.